Novel chemotherapy combination of carfilzomib with dexamethasone, cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of relapsed/refractory aggressive plasma cell dyscrasias.

Charlotte B WagnerKelley JulianBaylee BryanMary N SteinbachSamuel ShewanLindsay MaxwellMeghan VigilGhulam Rehman MohyuddinAmandeep GodaraBrian McCluneGlicelda Galarza FortunaDouglas Sborov

Published in: Leukemia & lymphoma (2024)

Keyphrases

multiple myeloma
low dose
high dose
acute lymphoblastic leukemia
acute myeloid leukemia
single cell
diffuse large b cell lymphoma
cell therapy
hodgkin lymphoma
stem cells
squamous cell carcinoma
combination therapy
bone marrow